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To investigate the effect of exogenous nitric oxide donor (PAPA NONOate) a drug which spontaneously 
release nitric oxide on the rate of wound healing and collagen synthesis on impaired wound healing in 
experimental diabetes. 12 male Sprague – Dawley rats were transferred to separate metabolic cages. 
Nine days before wounding, the rats were injected intraperitoneally (IP) with streptozotocin (STZ) (55 
mg/kg body weight in citrate buffer 0.1 mol/L, pH 4.5) to induce diabetes. The dorsal surface of each rat 
was properly shaved and given full thickness dermal wound. The test group (n = 6) was treated with 100 
µmole PAPA NONOate in phosphate buffer while control wounds (n = 6) received sterile phosphate 
buffer on the same day and every three days. Daily urine samples were collected at every 24 h intervals. 
To inhibit bacterial growth, 5 ml of 3 M HCl was added to each urine collection (pH = 1) and urine 
samples were kept frozen until analyzed (-70°C). Urinary nitrate (NO
-3
) was quantitated daily prior to 
wounding, and during wound healing (21 days) following external wound closure. The rate of wound 
healing was determined by video image analysis. PAPA NONOate treatment increased the rate wound 
healing in test group as compared to the control group. The nitric oxide donor PAPA NONOate may 
represent a potential treatment for impaired wound healing in diabetes by increasing the rate of 
collagen synthesis at the wound site. 
 





Wound healing is an orchestrated sequence of bio-
chemical changes which results in tissue repair Thimothy 
and Margret,. (2008). In diabetes all the stages of the 
complex wound  healing process including inflammation, 
proliferation, angiogenesis and matrix formation, are im-
paired (Dashti et al., 2004). During the early phases of 
wound repair, chemotaxis, phagocytosis, bacterial killing 
and antioxidant levels are decreased in diabetes (Witte et 
al., 2002; Bitar et al., 1996; Beer et al., 1997). Also, 
growth factor depletion, increased glucocortocoids levels 
(Bitar et al., 1997), decreased cell proliferation 
(Hehenberger et al., 1998; Goldstein et al., 1979) and up 
regulation of apoptosis (Darby et al., 2000) characterize 
the later phases of healing in diabetics, resulting in 
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synthesis is decreased in diabetic wound healing (Witte 
et al., 2002). Based on previous findings, the role of nitric 
oxide as a mediator of wound healing has been de-
termined (Witte et al., 2002, 2000).  
In diabetes, the level of nitric oxide is decreased in the 
wound environment. In diabetes, an endogenous 
deficiency in nitric oxide synthase (NOS) enzyme leads to 
decreased wound nitric oxide (NO) production and a wide 
range  of related pathologies, such as impaired 
cutaneous vasodilation, decreased neurogenic vascular 
response, diabetic neuropathy, endothelial cell function 
that inhibit the processes necessary for granulation tissue 
formation.  Accumulation of reparative collagen is also 
reduced. As a mediator of tissue repair, NO plays an 
important role in promotion of angiogenesis and cellular 
migration, increase wound collagen deposition and 
collagen cross linking, regulate vasodilation, inhibit 
platelet aggregation, inhibit endothelial - leukocyte cell 
adhesions,    modulate     endothelial     proliferation   and  










apoptosis, increase the viability of random cutaneous 
flaps, and enhance cellular immunomodulation and 
bacterial cytotoxicity (Dashti et al., 2004). NO is critically 
involved in the entire continuum of events associated with 
collagen synthesis in fibroblasts by an unknown 
mechanism and accelerates wound closure when applied 
topically at the wound site (Witte and Thornton, 2000). 
Reduced nitric oxide production in diabetic wounds has 
been shown to be associated with impaired healing and 
reduced collagen deposition (Thimothy et al., 2008). 
Failure of wound healing is a major cause of morbidity 
and mortality in diabetes (Terezelain and Hanson., 2009). 
Collagen molecule is one of the most fundamental 
constituents of connective tissue with a triple helical 
structure (Bitar et al., 1997; Hehenberger et al., 1998; 
Goldstein et al., 1979; Darby et al., 2000; Burgeson and 
Marcel,1992). Based on previous findings that diabetes is 
characterized by reduced nitric oxide levels in the wound 
environment, this study investigated whether exogenous 
nitric oxide supplementation with nitric oxide donor PAPA 
NONOate could reverse impaired healing in diabetes. 
The 24 h urine samples were collected throughout the 
healing period (21 days). Wound closure profiles were 
examined by video image every three days and urinary 
nitrate (NO
-3
)  output  was  measured  by  Griess reagent. 
MATERIALS AND METHODS 
 
PAPA NONOate [1- propamine, 3- (2-hydroxy–2–nitroso–1–propyl 
hydrazine)] was purchased from Alexis Co. (Switzerland). Low 
nitrate diet (2% L-arginie) was obtained from Pasture Institute, 
Tehran, Iran. Blood glucose levels were measured with glucose 
oxidize kit (Zist Chimy Chemical Co. Tehran, Iran). Male Sprague – 
Dawley rats (Tehran University of Medical Sciences animal house, 
Tehran, Iran) were acclimatized for one week, they were given 
water ad libitum, and fed a low nitrate containing diet (2% L- 
arginine). Animals were transferred to separate metabolic cages 
(Figure 1). Nine days before wounding, the test groups were 
injected intra peritoneally (IP) with streptozotocin (STZ) (55 mg/kg 
body weight in citrate buffer 0.1 mol/L, pH 4.5) to induce diabetes. 
Evidence of diabetes was confirmed by blood glucose levels 
greater than 250 mg/dL and excessive urination. 
Before wounding, the rats were anesthetized with Nembutal (40 
mg/kg i.p.). The dorsal surface of each rat was properly shaved and 
given full thickness dermal wound approximately 1 × 1 cm. The test 
group (n = 6) was treated with 100 µmole PAPA NONOate in 
phosphate buffer while control wounds (n = 6) received sterile 
phosphate buffer on the same day and every three days. Daily 
urine samples were collected at every 24 h intervals. To inhibit 
bacterial growth, 5 ml of 3 M HCl was added to each urine 
collection (pH = 1) and urine samples were kept frozen until 
analyzed (-70°C). Urinary NO
-3
 was quantitated daily prior to 
wounding, and during wound healing (21 days) following external 
wound closure. The rate of wound healing was determined by video 
image  analysis.  48 h following  wounding  and   every   three days,  



















































































Pre-wound 4.9 ±  0.21 4.9 ±  0.21 - - 
Early-wound 8.80 ± 0.70 9.59 ± 0.67 0.001 S 




wounds were videotaped using Nikon Colpix 5000. The urinary 
nitrate levels were determined using Griess reagent. The principle 
of this assay is reduction of nitrate by vanadium (III) combined with 
detection by acidic Griess reaction. The Griess reaction entails 
formation of a chromophore from the diazotization of sulfanilamide 
by acidic nitrite followed by coupling with bicyclic amines such as N-
1-naphthyl ethylenediamine. SPSS computer software was used for 





Interesting and promising results have been obtained 
from studies using non-soluble, polymeric PAPA 
NONOate as NO donating agent during cutaneous 
healing in rats. Topical application of NONOate was 
made on days 0, three, six, nine, 12, 15, 18 and 21. The 
mean pre wound urinary nitrate output for NONOate and 
control group was 4.9±0.21 µmol/day. The mean early 
wound urinary nitrate output for control and test group 
was 8.80±0.70 and 9.59±0.67 µmol/day, respectively. 
The mean post wound urinary nitrate output for control 
and test group was 8.80±0.90 and 9.60±0.93 µmol/day, 
respectively. The urinary NO
-3
 profiles for diabetic rats 
with PAPA NONOate and controls is shown in Figure 2 
and Table 1. Control diabetic rats had significantly less 
urinary NO
-3
 output than the test group (P<0.001). A 
significant peak in NO
-3
 output occurred between days 12 
to 13 when the external wound was approximately 65% 
closed. Diabetic rats whether treated with PAPA 
NONOate or not, exhibited a significant increase in 
urinary NO
-3
 output within 24 to 48 h post wounding 
period. During a three day period, all the rats were 
removed from their cages and video imaged. The wound 
closure profiles for all the rats are shown in Figure 3 and 
Table 2. There is a significant difference (P<0.001) in 
wound closure profiles between the test and the control 
group. Photographs of full thickness thermal wounds for 
the control and the test group on days 0, 12 and 21 are 
shown in Figures 4 and 5, respectively. 
Therefore, PAPA NONOate treatment can increase the 
rate of wound healing and collagen synthesis in diabetic 





NO is important in the process wound healing and tissue 
repair. NO potentiates antiseptic effects, minimizing 
intraoperative wound contamination. It, besides, 
stimulates   endothelial   and    basal  cells  of   epidermis 









































Control (%) Test (%) p-Value Significance 
3 93 ± 0.33 89 ± 0.15 0.001 S 
12 55 ± 0.11 35 ± 0.43 0.001 S 




proliferation (Larichev et al., 2011). 
Refractory wound is a severe complication that leads to 
limb amputation in diabetes, and is also a leading cause 
of hospitalizations in diabetic patients with limited 
treatment regimens. However, the underlying 
mechanisms remain to be fully elucidated. Various 
factors contribute to delayed diabetic wound healing, 
such as growth factor, nitric oxide (NO), reactive oxygen 
species (ROS), matrix metalloproteinases (MMPs), 
microRNA, endothelial progenitor cells (EPCs), etc 
(Sheng Li et al., 2010). 
NO and its interrelationship with essential growth 
factors is involved in the entire events associated with 
wound repair. NO is often impaired in rats with diabetes. 
Diabetic rats have a reduced ability to generate NO from 
L-arginine which is reflected by direct measurements of 
plasma nitrate and nitrite levels. NOS from which NO is 
derived is a pH dependent enzyme which is active at 
slightly alkaline (basic) conditions but is suppressed by 
acidic conditions. In diabetes, glycolysis and ketoacidosis 
force pH towards acidic conditions and this may account, 
in part, for the reduced production of NO (Jian-dong et 
al., 2005). 
Adequate oxygen is necessary for the activity of NOS 
and therefore NO. Circulation is notoriously impaired in 
diabetic patients, which limits available NOS and NO. 
Lastly, people with diabetes often experience elevated 
glucose levels. Some of this glucose becomes 
incorporated into hemoglobin and is measured as 
glycosylated hemoglobin (Hob) or HgbA1C. Glycosylated 
hemoglobin binds to NO as nitrosothiols very tightly so 
that any NO that is formed cannot be easily released 
from red blood cell (RBC) to help maintain blood flow 
through smooth muscle cell relaxation. When available 
NO is tightly bound to glycosylated hemoglobin its 
release is limited in smooth muscle cells where NO is 
required for essential cellular functions. Similarly, the NO 
donor molsidomine (N-ethoxycarbomyl-3-
morpholinylsidnonimine) or NO releasing poly (vinyl 
alcohol) hydrogel dressings are also shown to partially 
restore such healing impairment in STZ-induced diabetic 
rats. Collectively, impairment of skin NO function 
represents an important factor for delayed wound healing 
in diabetes and strategies aimed at restoring cutaneous 
NO  bioavailability  with  NO donors or NOS gene therapy 
may serve as effective means for diabetic wound healing 
















(Jian-dong et al., 2005). 
The capacity of a nitric oxide-releasing nanoparticle 
(NO-np) to treat wounds infected with Acinetobacter 
baumannii (Ab) was examined. It was found that the NO-
nps were therapeutic in an experimental Ab murine 
wound model. Treatment with NO-nps significantly 
accelerated healing of infected wounds (Mihu et al., 
2010). 
Collagen is one of the principle structural proteins 
which play an important role in wound healing (Bilden 
and Oktay,1999). Collagens are a large family of 
structural proteins in the extra cellular matrix of 
eukaryotes (Bulfield., 1990). During wound healing, the 
collagen molecules, after being secreted by the cells, 
assemble to form fibers for the functional integrity of 
tissues (Freeman et al., 1988). Diabetes is characterized 
by a nitric oxide – deficient state accompanied by 
decreased collagen deposition at the wound site. 
The nitric oxide donor PAPA NONOate may represent 
a potential treatment for impaired wound healing in 
diabetes by increasing the rate of collagen synthesis at 
the wound site. It has been shown that diabetic wounds 
are more susceptible to nitric oxide donor treatment since 
the wound is deficient in nitric oxide (Witte et al., 2002). 
Furthermore, the previous  results show that topical 
application of S-nitrosoglutathione (GSNO) is effective in 
the treatment of ischemic wounds, leading to a significant 
improvement in the wound healing (Georgii et al., 2010). 
 Also, our previous study on DETA NONOate showed, 
this compound can partially improve impaired healing in 
diabetes by increasing the rate of collagen synthesis 
(Dashti et al., 2010). 
In the previous studies, it was shown that the effect of 
nitric oxide donor administration may be dependent on a 
threshold rather than the dose. So therefore, further 
studies should be performed to demonstrate a correlation 
between levels of nitric oxide donors at the wound site 
and its outcome. In summary, administration of PAPA 
NONOate can partly restore the impaired healing in 
diabetes by increasing the rate of collagen synthesis. 
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